AG-13958
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
319460-94-1
AG-013958
C08359-2mg
VEGFR
Protein Tyrosine Kinase
CC1=NN (C (=C1) C (=O) NC2=C (C=CC (=C2) NC3=CC4=C (C=C3) C (=NN4) C=CC5=CC=CC=N5) F) C
C26H22FN7O
AG-13958 (AG-013958), a VEGFR tyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD) .
3 years -20°C powder
Beschrijving
AG-13958 Beschikbaar in 2 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Anti-TNF-α (Adalimumab), humanized Antibody
A1048-100
100 µg
PEPTIC DIGEST OF ANIMAL TISSUE (MEAT PEPTONE)
P16-102-01
500 g
GelRed® Agarose LE
#41029-5G
1x 5 g
HT115 (DE3) Super Competent Cells
D1045S
10x 100 μL
HT115
ACC-130
10 Tubes
Rat Reticulon-4 receptor, RTN4R ELISA Kit
MBS9325746-01
48 Well
Starfish Genomic DNA
GSF-390
0.025 mg
NPM2
570475-01
50 µg
Recent gezochte producten
Anti-EGFR Antibody (aa1048-1077) IHC-plus
MBS2400374-01
0.2 mL
BIBR-1048 10mg
A10139-10
10 mg
BIBR-1048 100mg
A10139-100
100 mg
BIBR-1048 10mM * 1mL in DMSO
A10139-10mM-D
10 mM x 1mL in DMSO
MK-2048 100mg
A11135-100
100 mg
Ro 61-8048 100mg
A12833-100
100 mg
MMV390048 100mg
A13566-100
100 mg
VCE-004.8 100mg
A18549-100
100 mg